Using Accelerometers to Measure Physical Activity in Older Patients Admitted to Hospital. by Hartley, Peter et al.
Clinical Study
Using Accelerometers to Measure Physical Activity in
Older Patients Admitted to Hospital
Peter Hartley ,1,2 Victoria L. Keevil,1,3 KateWestgate ,4 TomWhite,4
Søren Brage ,4 Roman Romero-Ortuno,1,3,5 and Christi Deaton3
1Department of Public Health and Primary Care, University of Cambridge, CB2 0SR, UK
2Department of Physiotherapy, Cambridge University Hospital NHS Foundation Trust, CB2 0QQ, UK
3Department of Medicine for the Elderly, Cambridge University Hospital NHS Foundation Trust, CB2 0QQ, UK
4MRC Epidemiology Unit, University of Cambridge, CB2 0SL, UK
5Trinity College Dublin, Discipline of Medical Gerontology, Mercer’s Institute for Successful Ageing,
St James’s Hospital, Dublin 8, Ireland
Correspondence should be addressed to Peter Hartley; ph492@medschl.cam.ac.uk
Received 9 August 2018; Accepted 8 October 2018; Published 18 October 2018
Academic Editor: JacekWitkowski
Copyright © 2018 Peter Hartley et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Low levels of physical activity in older patients during hospitalization have been linked to loss of functional ability.
Practical methods of measuring physical activity are needed to better understand this association and to measure the efficacy of
interventions. The aims of this study were to evaluate the feasibility of using accelerometers to discriminate between lying, sitting,
standing, and standing and moving and to determine the acceptability of the method from the patients’ perspective.Methods. A
convenience sample of 24 inpatientswas recruited. Participantswore accelerometers on their thigh and on their lower leg (just above
the ankle) for 48 hours during their hospitalization. Postural changes andmovement during the 48 hours were differentiated using
derived pitch angles of the lower leg and thigh, and nongravity vector magnitude of the lower leg, respectively. Results. On average,
patients were lying for 61.2% of the recording time, sitting for 35.6%, standing but not moving 2.1%, and standing andmoving 1.1%.
All participants found the accelerometers acceptable to wear. Conclusions. The methodology described in this study can be used to
differentiate between lying, sitting, standing, and moving and is acceptable from a hospitalized older person’s perspective.
1. Background
Low levels of physical activity in older hospitalized adults are
well documented [1–4] and have been linked with declines
in functional ability [5] and muscle strength [6]. As such,
there is a need to measure physical activity when investigat-
ing hospital-associated functional decline in older patients.
Accelerometers are tools used to objectively measure levels
of activity in research and have been used extensively in
community-dwelling adults [7, 8].
Accelerometers have been worn on a variety of anatomi-
cal positions, but most often worn on the hip or wrist, with
the latter being the most common due to its high accept-
ability to study participants [7–9]. In community cohorts
and epidemiological studies, accelerometer data are usually
reported in terms of time spent at different intensities of
physical activity [10]. In hospital cohorts, this information
is somewhat redundant due to the severity of inactivity
and low intensity of all activity. Typically, research using
accelerometer-measured activity in hospital has used step
count or time spent upright (standing or walking versus
sitting or lying) to quantify activity [11]. However, it would be
desirable to measure hospital activity in terms of time spent
in specific postures (e.g., lying, sitting, and standing) and
time spent walking [12–14]. This is because a more nuanced
characterization of mobility patterns in older hospitalized
patientsmay facilitate the design of specific physical interven-
tions to try to combat hospital-associated functional decline.
For instance, it has been suggested that sitting in a chair
may have a therapeutic benefit in some patients [15, 16], but
prolonged sitting compared to resting lying on a bed may
also be detrimental [17]. To accurately differentiate between
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lying in bed, sitting in a chair, and standing, two sensors are
required which can be positioned either on the thigh and
lower leg [13, 14] or on the sternum and thigh [12].
To our knowledge, six studies have validated methods
for using two accelerometers in hospitalized patients for
specifically measuring posture [12–14, 18–20], including four
in an acute ward setting [13, 14, 18, 20]. Four of the six studies
placed accelerometers on the thigh and lower leg [13, 14, 18,
19] and two on the thigh and sternum [12, 20]. Four of these
studies specified the accelerometer model used: one study
used the ADXL202 [12], one used the ActivPAL [20], and
two used the PAL2 device [18, 19]. Two studies reported their
algorithms for defining lying, sitting, and standing positions
in relation to the detected angles of the accelerometers [12,
14]. Pedersen et al. [14] attached sensors to the participants’
thigh and lower leg, andCulhane et al. [12] attached sensors to
the thigh and sternum. Both reported high levels of accuracy
in all three positions. Two studies had a fourth category of
“movement” [12, 20], one using the ActivPAL and one using
ADXL202 accelerometers; Culhane et al. [12] reported high
rates of movement detection accuracy, and Taraldsen et al.
[20] reported low level of step count accuracy when walking
speed was below 0.47 m/s.
The aims of this feasibility study were to develop a
method to discriminate between lying, sitting, standing, and
moving (upright), in older hospitalized patients using two
accelerometers (on the thigh and lower leg), and to determine
the feasibility and acceptability of the method from the
patients’ perspective.
2. Methods
2.1. Study Design. This is a feasibility study using a cross-
sectional single center cohort design. Ethical approval was
granted by the South Central Hampshire A Research Ethics
Committee (reference 17/SC/0219).
2.2. Setting. The study was conducted on inpatient wards
of the Department of Medicine for the Elderly (DME) at
Cambridge University Hospitals (CUH) NHS Foundation
Trust, England,UnitedKingdom.CUH is a tertiary university
teaching hospital in the English National Health Service
(NHS) with approximately 1000 inpatient beds. DME wards
have approximately 150 beds and specialize in the provision
of Consultant (i.e., senior physician)-led multidisciplinary
Comprehensive Geriatric Assessment for older adults admit-
ted to the hospital. The clinical characteristics of this setting
have been described elsewhere [21, 22].
2.3. Study Period. Patients were recruited between May and
October 2017.
2.4. Population. Convenience sample of patients admitted to
DME wards over the age of 70, under the care of a DME
Consultant (Senior Attending Physician), with an expected
hospital stay of more than 72 hours. Our Patient and Public
Involvement (PPI) group suggested that men and women
might have different views regarding acceptability of wearing
accelerometers.We therefore recruited 12men and 12women,
Figure 1: Placement of accelerometers; the accelerometers are
orientated with the micro-USB port towards the feet.
using the guidance of the National Institute for Health
Research (NIHR) of recruiting 12 participants per group in
a feasibility study [23].
Exclusion criteria are as follows: inability to provide
informed consent as assessed by the researcher taking con-
sent; if the patient was receiving end of life care; disagreement
to participation by the DME Consultant in charge of the
patient’s care; if the clinical team had any concerns regarding
skin integrity around proposed accelerometer sites; allergy
to adhesive dressings; or if the patient was already actively
involved in another research study.
2.5. Procedures. Potential participants were identified by
members of the clinical team who sought permission from
the individuals for them to be approached by a member of
the research team. If permission was given, a member of the
research team (PH, a Physiotherapist with 8 years’ clinical
experience) would discuss the study with the participant and
provide them with further written information regarding the
study.Written informationwas produced in conjunctionwith
the PPI group prior to the study. Participants were given
24 hours to consider their participation before being asked
to provide written consent. Mental capacity was assessed at
both meetings by PH and confirmed verbally with the DME
Consultant.
After providing written consent, participants were fitted
with two accelerometers (AX3,Axivity,Newcastle uponTyne,
UK) on the same leg, the first on the front of the thigh,
proximal to the patella (a third of the way between the
knee and the hip). The second sensor was placed on the
side of the lower leg approximately 5cm above the lateral
malleolus of the ankle (Figure 1). The lateral side of the lower
leg was chosen as opposed to the anterior to minimize the
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Questionnaire to assess acceptability of wearing accelerometers
(1) How would you describe your experience of wearing the accelerometers?
(1) Not uncomfortable
(2) Uncomfortable all the time
(3) Uncomfortable at times
Any comments:









Any comments (if answered no or unsure, please expand as to whether you found either the thigh or
ankle sensor to be particularly problematic):
Box 1: Acceptability questionnaire.
risk of excessive pressure on the skin if the participants
were to lie in bed with their legs crossed. The research team
considered the potential risk of increased pressure on the
skin if the participants were to lie on their side. However
due to the pressure relieving mattresses the hospital uses, the
risk was felt to be sufficiently low to proceed. In addition,
the accelerometer sites were checked daily for comfort and
skin integrity.The accelerometers were placed on the right leg
unless there were clinical reasons prohibiting its placement
(e.g., skin lesion) or the participant had a strong preference
for the left leg. The thigh and lower leg sensor locations
were preferred to using the thigh and sternum locations by
both our PPI group and members of the clinical teams. The
preference of location was based on both practical reasons
(e.g., potential interference with routine clinical procedures)
and the expected acceptability to patients. Following advice
from our PPI group and clinical teams, the accelerometers
were placed over a piece of gauze to avoid direct friction with
the skin and fixed to the skin with a 10cmby 12cm transparent
dressing (3M Tegaderm Film).The AX3 can be submerged in
water at a 1.5m depth for 1 hour and therefore there were no
restrictions on participants being able to shower or wash.The
device has been used in the UK Biobank study where it was
worn on the wrist by over 100,000 participants [9] and has
demonstrated equivalent signal vector magnitude output on
multiaxis shaking tests to the GENEActiv accelerometer [24].
Participants were asked to wear the sensors continu-
ously over a 48-hour period. Patients were instructed to
inform clinical staff if they experienced any discomfort at
the accelerometer sites, in order to have them immediately
removed. A member of the research team checked skin
integrity (through the transparent dressing) on a daily basis.
Following the 48-hour monitoring period, a member of the
research team removed the accelerometers and participants
were asked to complete a questionnaire regarding the accept-
ability of their monitoring experience (Box 1). A 48-hour
wear time was felt to be a sufficient period of time to assess
acceptability by both the research team and PPI group. If
a patient’s discharge date was changed to within the 48-
hour period after study commencement, or if he/she needed
to undergo an MRI scan during the monitoring period,
the accelerometers were removed and the questionnaire was
completed at that point.
2.6. Other Measurements. For descriptive purposes, we
recorded the participants’ age, sex, comorbidity burden, acute
illness severity, degree of frailty, level of mobility, reason
for hospital admission, and length of hospital stay prior to
participation in the study.
Comorbidity burden was measured using the Charlson
Comorbidity Index (CCI), which is based on patients’ diag-
noses as coded by the World Health Organization’s Interna-
tional Classification of Diseases (10th version) [25]. Acute
illness severity was measured by the National Early Warning
Score [26], recorded at the points of study entry and exit.
Frailty was measured using the Clinical Frailty Scale
(CFS).The scoring of the CFS is based on a global assessment
of patients’ comorbidity symptoms, cognition, and their
level of physical activity and dependency on activities of
daily living [27]. The possible scores are 1 (very fit), 2
(well), 3 (managing well), 4 (vulnerable), 5 (mildly frail), 6
(moderately frail), 7 (severely frail), 8 (very severely frail),
and 9 (terminally ill). The Modified Functional Ambulatory
Category (MFAC) was used to describe the participants’ level
of functional mobility. The MFAC is a seven-point scale with
the following scores: 1: cannot ambulate and requires manual
assistance to sit; 2: is able to sit for a minute without support;
3: requires continuous manual assistance of 1 person to sup-
port bodyweight in order to ambulate; 4: requires continuous
or intermittent lightmanual assistance of 1 person tomaintain
balance when ambulating; 5: requires supervision for safety
reasons when ambulating; 6: is able to ambulate indepen-
dently on level surfaces; 7: is able to ambulate independently
on level and nonlevel surfaces [28]. As mobility was only
assessed in the hospital ward (on a level surface), for the
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purposes of this study participants could score a maximum
of 6. Members of the direct clinical care teams described each
participant’s functional mobility at the beginning and end of
their participation in the study to provide an MFAC score.
Acceptability was assessed by a specifically designed
questionnaire (Box 1); other acceptability outcomes were as
to whether the sensors had been worn for the intended time
period; or if any concerns had been raised by participants,
their families, or members of staff regarding skin integrity or
bruising around the sensor sites.
2.7. Accelerometer Data Acquisition. Theaccelerometers were
set up to record movement with a sampling frequency of 100
Hertz and a range of ± 4g using OMGUI software developed
by Newcastle University [29]. Following removal of the
devices, the same software package was used to download the
recorded data.
2.8. Accelerometer Data Processing. Data processing was per-
formed using pampro [30], an open source software package
(https://github.com/Thomite/pampro). The raw acceleration
data was autocalibrated to local gravity using the method
described by van Hees et al. [31]. Due to the placement of
the devices and the relatively short duration of measurement,
calibration factors were calculated based on all data collected
by each device, rather than within a single record. Machine
noise was filtered out by applying a low-pass filter at 20Hertz.
To define the participants’ position or activity, three
variables from the accelerometers were derived: Euclidean
Norm Minus One (ENMO), thigh pitch (elevation) angle:
and lower leg pitch angle. ENMO was calculated using the
following formula: 𝐸𝑁𝑀𝑂 = (√𝑥2 + 𝑦2 + 𝑧2) − 1, where x, y
and z refer to the acceleration in g detected along the x, y, and
z axes, respectively. ENMO subtracts 1g from the Euclidian
norm (vector magnitude) and truncates negative values to
zero at sample level to remove the gravity component from
the signal, thereby isolating activity-related acceleration [32].
It is normal practice to use nonwear detection procedures to
identify when the accelerometers have been removed [33]. As
only the research team fitted or removed the accelerometers,
compliance with wear was known and therefore nonwear
detection was not required.
When the accelerometer is still, the pitch angle along
its primary axis x is calculated using the following for-
mula: tan−1(𝑥/√𝑦2 + 𝑧2))(180.0/𝜋). The formula provides
angles from +90∘ to -90∘, where +90∘ or -90∘ represent the
accelerometer’s x-axis being aligned parallel to the earth’s
gravity vector (straight up or straight down, respectively),
and 0∘ represents the accelerometer’s x-axis angle being
aligned perpendicular to the earth’s gravity vector. Using our
orientation of the accelerometers (micro-USB port towards
the feet), 90∘ represented the patient being “upright” or
“standing”.
Each of the three signals was summarized from sample-
level data into 5-second epochs. Before further variables
were derived, a correction was made for the lower leg
accelerometer pitch angle. When the accelerometer was
attached to the patient, the researchers aimed to align the
accelerometer with the lower leg, so that when the lower
leg was perpendicular to the floor, the pitch angle would
be -90∘. Due to the practical constraints of positioning a
patient when fitting the accelerometer, this was not always
accurate. As all included participants were known to have
walked during the study period it was assumed that the
minimum lower leg pitch angle was -90∘ in all participants.
All lower leg pitch recordings for each participant were
therefore reduced by the difference between their minimum
recorded pitch angle and -90∘. Every 5-second window was
classified as one of: “lying”, “sitting”, “standing”, and “moving
(upright)”, based on the rules given in Figure 2. The static
positions were based on the algorithm validated by Pedersen
et al. [14]. The levels of correspondence between inferred
position from accelerometer data and observed positions for
lying, sitting, and standing were reported by Pedersen et al.
[14] as 90.8–100%, 95.3–98.6%, and 89.6–96.5%, respectively.
ENMO values were used from the lower leg accelerometer
to define whether or not a person was moving (when
already determined to be standing according to the positional
criteria). Our previous work has determined usual walking
speeds in this population at the point of hospital discharge
as 0.33 m/s (IQR 0.21–0.50 m/s), a very low speed compared
to those reported in community based samples [34]. A cut-
off of ENMO value of >13 milligravity units (mg) from
the accelerometer on the lower leg was used to define a
participant as “moving”. This value has previously been used
with wrist accelerometers to define stationary periods [9, 35].
We tested the threshold value using data from accelerometers
worn by members of the research team on their lower leg
when stationary, and when walking on a treadmill at 0.1 m/s.
Stationary and walking at 0.1 m/s, median (IQR) ENMO
values were 3.7mg (1.7–10.5mg) and 16.4mg (13.9–20.1mg),
respectively.
2.9. Data Analysis. Statistics were presented as mean and
standard deviation, or as a count and percentage for cate-
gorical variables. For continuous variables with a nonnormal
distribution we reported median and interquartile range
(IQR) or median and range if the number of data points was
less than 25.
3. Results
Participant characteristics are described in Table 1. Female
participants had a median age of 81.5 years and male par-
ticipants of 79.5 years. The median MFAC score when the
accelerometers were first attached to the participants was
5 (requiring supervision to ambulate for safety purposes),
although this improved to 6 (able to walk independently
on level surfaces) by the end of the measurement period.
Other clinical characteristics and outcomes are summarized
in Table 1.
Three participants’ activity data was not captured; set-up
errors were made for two participants, on one or both of the
accelerometers, and in one case the lower leg accelerometer
fell off and the participant declined to have it refitted as they
were concerned that it could get lost. In five further cases, the
accelerometers were removed prematurely due to earlier than
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Figure 2: Algorithm for determining participant posture and movement (𝜃T = pitch angle of thigh accelerometer, 𝜃L = pitch angle of lower
leg accelerometer, and ENMO from lower leg accelerometer).
Table 1: Participant characteristics.
All Female Male
Clinical characterization (n = 24) (n = 12) (n = 12)
Age (years) 80.5 (70.0–95.0) 81.5 (71.0–89.0) 79.5 (70.0–95.0)
Days since admission 4 (3–7) 5 (3–8) 3 (3–5)
CCI 1.5 (0–9) 1 (0–6) 2 (0–9)
CFS 5 (1–7) 4 (1–7) 6 (2–7)
MFAC Start 5.5 (2–6) 5.5 (2–6) 5 (2–6)
MFAC End 6 (2–6) 6 (2–6) 6 (2–6)
NEWS Start 1.5 (0–6) 1 (0–4) 2.5 (0–6)
NEWS End 1 (0–5) 1 (0–4) 1.5 (0–5)
Accelerometer characterization n = 21 n = 9 n = 12
Average ENMO lower leg (mg) 2.1 (±11.2) 2.6 (±12.2) 1.9 (±10.6)
Time spent lying (%) 62.6 (±16.3) 54.4 (±10.0) 68.7 (±17.7)
Time spent sitting (%) 34.2 (±14.7) 41.8 (±8.9) 28.5 (±15.9)
Time spent standing (%) 2.0 (±1.9) 2.5 (±2.4) 1.7 (±1.5)
Time spent moving (upright) (%) 1.2 (±1.1) 1.3 (±0.9) 1.1 (±1.2)
Data presented as median (range) or mean(±SD).
CCI = Charlson Comorbidity Index, CFS = Clinical Frailty Scale, MFAC =Modified Functional Ambulatory Category, NEWS =National EarlyWarning Score,
and ENMO = Euclidean Norm Minus One.
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Figure 3: Flow of participants through study.
expected discharges or MRI scans, but in all those cases at
least 24 hours of data was collected (Figure 3).
All participants completed the acceptability question-
naire. All participants reported ‘no discomfort’, with 16 par-
ticipants reporting similar comments to the effect of having
forgotten that they were wearing the accelerometers. All
participants reported that their sleep had not been affected by
wearing the accelerometers. All but one participant reported
that they would wear the accelerometers again in a future
study.
The levels of activity for each participant are summarized
in Table 1 and Figure 4. On average, patients were lying for
62.6% (±16.3) of the recording time, sitting for 34.2% (±14.7),
standing but not moving 2.0% (±1.9), and standing and
moving 1.2% (± 1.1). Examples of participant activity over the
study period are illustrated in Figure 5.
4. Discussion
This study described a novel method of measuring modalities
of physical activity in older patients during an acute hospital-
ization. The method was feasible and allowed differentiation
between lying, sitting, standing, and moving (upright). Fur-
thermore, this measurement was considered to be acceptable
from the patients’ perspective.
Our study built upon previous work using 2 accelerom-
eters to differentiate positions of hospitalized patients. We
believe this is the first study to use accelerometers on the thigh
and lower leg to differentiate between lying, sitting, standing,












Figure 4: Summary of posture andmovement during measurement
period.
Compared to the PAL2 device, the AX3 device and the
methods we used to attach it to the participants may be
more acceptable. Using the PAL2 device, Kramer et al. [18]
reported two of the eight participants reported the device
being uncomfortable.



















































































Figure 5: Examples of participant’s activity during study period.
The amount of time spent standing or walkingwas similar
to that recorded by other studies of similar populations,
though the amount of time spent lying was lower. Pedersen et
al. [14] reported that their ambulatory patientswere lying 70%
of the time, sitting 21%, and standing or walking 4%; Brown
et al. [1] reported participants lying 83% of the time, sitting
12.9%, and standing or walking 3.8%.
We used a convenience sample, and the duration of
the study was a maximum of 48 hours; it is possible that,
with a larger random sample and longer study duration,
the reported acceptability of the devices may have been
different. Furthermore, our participants had on average been
in hospital 4 days prior to starting the study; it is possible
that they would have found the accelerometers less acceptable
in the first days of hospitalization. The movement threshold
between standing and moving has not been validated in
the patient population and is likely to be inaccurate at
walking speeds of less than 0.1 m/s. This is relevant given the
known slow walking speed of our population; however the
significance of standing versus walking at such a slow speed
is not known.
5. Conclusion
The methodology described in this study can be used to
differentiate between lying, sitting, standing, and standing
and moving and is very acceptable from a hospitalized
patient’s perspective. Work is now required to examine
the significance of the derived variables on hospital out-
comes.
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